Ignite Creation Date:
2024-05-06 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05121103
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2021-10-18
Brief Title:
A Study of the Safety Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With RelapsedRefractory Multiple Myeloma and RelapsedRefractory Diffuse Large B Cell Lymphoma
Sponsor:
Epizyme Inc
Organization:
Ipsen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-27
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-18
First Submit QC Date:
November 15 2021
Study First Post Date:
2021-11-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL